- On Friday, U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas, suspended the approval of mifepristone, making the sale of the abortion pill illegal in the U.S.
- The judge ruled that the FDA ignored the risks in approving the drug. Kacsmaryk also noted that his ruling would not take effect for one week to give U.S. President Joe Biden‘s administration seven days to appeal to the 5th U.S. Circuit Court of Appeals.
- The White House is planning to start new discussions with abortion pill manufacturers and U.S. pharmacy chains to push back against the ban on mifepristone as it appeals a Texas court ruling suspending the drug’s approval.
- Discussions between the Biden administration, pill manufacturers, and pharmacies have been ongoing for months, Reuters reported, but Friday’s decision brings fresh urgency.
- In January, the FDA allowed pharmacies to offer abortion pills, mifepristone, in the U.S.
- No retail pharmacies are currently certified to dispense mifepristone, and many are going through the certification process.
- It was not immediately clear which companies would be involved in these discussions. The White House declined to comment.
- Major U.S. manufacturers of abortion pills include GenBioPro Inc and Danco Laboratories. Pharmacy chains dispensing such pills include Walgreens Boots Alliance Inc (NASDAQ:WBA), CVS Health Corp (NYSE:CVS), and Rite Aid Corp (NYSE:RAD).
- In March, Walgreens said it would not dispense abortion pills in the 20 states amid a shifting policy landscape, threats from state officials, and pressure from anti-abortion activists.
- Reuters added that politics makes it easier for the White House to make its case to the public that the FDA approval of the drug was accurate and mobilize activists and supporters to turn the issue into one that resonates with voters ahead of the 2024 presidential elections.
- Photo via Wikimedia Commons
Antero Midstream Sees FY24 Net Income $405M-$455M; Adjusted Net Income Of $460M-$500M
2024 GuidanceAntero Midstream is forecasting Net Income of $405 to $445 million and Adjusted Net Income (adjusted for amortization of customer relationships and effective tax rate impact) of $460 to
